MedTrace Logo

Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda

NCT01579214 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 183

Last updated 2018-01-04

Study results available
· View outcomes & findings →

Summary

The investigators will study the efficacy of a novel cellular phone messaging system to communicate health information and facilitate early return to clinic after abnormal laboratory results in rural Uganda.

Conditions

Interventions

OTHER

Cellular Phone Text Messages

Cellular phone text message formats to be sent to participants after abnormal laboratory results to communicate information and request early return to clinic.

Sponsors & Collaborators

  • Mbarara University of Science and Technology

    collaborator OTHER

  • Fogarty International Center of the National Institute of Health

    collaborator NIH

  • Harvard University

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Mark Siedner, MD MPH · Massachusetts General Hospital

  • Bosco Bwana, MD · Mbarara University of Science and Technology

  • David R Bangsberg, MD MPH · Massachusetts General Hospital Center for Global Health

  • Jessica Haberer, MD MS · Massachusetts General Hospital Center for Global Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2013-12-31
Completion
2015-04-30

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01579214 on ClinicalTrials.gov